drugset / Trial / NCT07699120
Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety and tolerability of BRC-002, an investigational botanical drug from cannabis, in healthy adults. The study will also assess how the body processes BRC-002 and whether taking it with food affects how it is absorbed or metabolized. The results of this study will help support further clinical development of BRC-002 and guide dose selection in patient populations.
Timeline
- Start
- 2026-06-15
- Primary completion
- 2026-10
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BRC-002 | Unknown | — | Oral |
Indications
No indication recorded.